NCT00620256 arm group 6420b4a1ec3562336d5a1a524273c038 [clinicaltrials_resource:NCT00620256/arm-group/6420b4a1ec3562336d5a1a524273c038]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00620256 arm group 6420b4a1ec3562336d5a1a524273c038 [clinicaltrials_resource:NCT00620256/arm-group/6420b4a1ec3562336d5a1a524273c038]
Bio2RDF identifier
NCT00620256/arm-group/6420b4a1ec3562336d5a1a524273c038
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 20b4a1ec3562336d5a1a524273c038
description [clinicaltrials_vocabulary:description]
Timolol gel forming solution, ...... eye(s) at 8 PM, for four weeks
identifier
clinicaltrials_resource:NCT00620256/arm-group/6420b4a1ec3562336d5a1a524273c038
title
NCT00620256 arm group 6420b4a1ec3562336d5a1a524273c038
@en
type
label
NCT00620256 arm group 6420b4a1 ...... 0b4a1ec3562336d5a1a524273c038]
@en